Alvin Krishna, MD (@akrishnamd) 's Twitter Profile
Alvin Krishna, MD

@akrishnamd

Radiation Oncology Resident at Tufts Medical Center/ Beth Israel Deaconess Medical Center 🧬 | GreenHealth Lab 🌳| #GeriOnc #Radiopharm | Views are my own |

ID: 1537256548438880256

calendar_today16-06-2022 02:11:47

60 Tweet

372 Takipçi

909 Takip Edilen

Alvin Krishna, MD (@akrishnamd) 's Twitter Profile Photo

When we treat the disease, we heal the body. When we treat patients’ fears, we heal their minds. When we treat the person, we heal the soul. Great commentary by Dr Chandrakanth Are on the sacred and sacrosanct physician - patient relationship. ascopost.com/issues/march-2…

Alvin Krishna, MD (@akrishnamd) 's Twitter Profile Photo

So grateful to have matched in my dream speciality of Radiation Oncology at Tufts/ Brown University! I could not have done this without the unwavering support and love from my wife, family and friends throughout this journey. #Match23 #RadOnc

So grateful to have matched in my dream speciality of Radiation Oncology at Tufts/ Brown University! 

I could not have done this without the unwavering support and love from my wife, family and friends throughout this journey. 

#Match23 #RadOnc
Chad Tang, MD (@chadtangmd) 's Twitter Profile Photo

Kids asleep,🧵time: EXTEND is randomized basket trial testing whether MDT improves PFS for oligometastatic cancers. The primary analysis for each histology-specific basket. Thanks to JAMA Oncology for reporting the prostate intermittent hormone basket here: bit.ly/3mgrQfE

Kids asleep,🧵time: EXTEND is randomized basket trial testing whether MDT improves PFS for oligometastatic cancers. The primary analysis for each histology-specific basket. Thanks to <a href="/JAMAOnc/">JAMA Oncology</a> for reporting the prostate intermittent hormone basket here: bit.ly/3mgrQfE
ASTRO (@astro_org) 's Twitter Profile Photo

Matthias Guckenberger The New York Times The Telegraph The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement regarding the PROSPECT clinical trial for patients with rectal cancer: astro.org/News-and-Publi…

<a href="/Mat_Guc/">Matthias Guckenberger</a> <a href="/nytimes/">The New York Times</a> <a href="/Telegraph/">The Telegraph</a> The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement regarding the PROSPECT clinical trial for patients with rectal cancer: astro.org/News-and-Publi…
ASTRO (@astro_org) 's Twitter Profile Photo

ASTRO is proud to join 600+ organizations and 3,500+ people in urging strong support for the NIH. Investing in research means investing in better treatments, cures, and patient outcomes.